One Drug Pricing Order Is Still Missing; Another Draws Fire

A promised executive order that would tie drug prices to their costs in other countries has yet to emerge, although President Donald Trump has promoted the order as part of his re-election campaign. Meanwhile, payers and PBMs are continuing to push back against three executive orders the Trump administration issued in July with the intention of lowering drug prices, one of which would overhaul the Medicare Part D prescription drug rebate system.

Avalere Health founder Dan Mendelson tells AIS Health that the disjointed rollout of the executive orders doesn’t alter their impact.

© 2023 MMIT
Peter Johnson

Peter Johnson

Peter has been a reporter for nearly a decade. Before joining AIS Health, Peter covered a wide variety of topics in his hometown of Seattle, where he continues to live. Peter’s work has appeared in publications including The Atlantic and The Stranger. Peter attended Colby College.

Related Posts

pills-in-dollar-sign
September 28

Retail Prescription Drug Spending Growth May Slow Down in Next Decade

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
September 28

News Briefs: Independent Pharmacists Seek ‘Payback’ From PBMs in CVS Lawsuit

READ MORE
person-leaning-out-of-line
September 28

‘Transparency-Rx’ Execs Explain Why They’re Breaking Rank, Backing PBM Reform

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today